Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Therapeutische Umschau. Revue Therapeutique|October 19, 2000
[Management of adverse drug effects]R G SchliengerDrugs & Aging|April 17, 2003
HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?Raymond G Schlienger, Christoph R MeierAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?Raymond G Schlienger, Christoph R MeierDrug Safety|June 21, 2005
Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance dataIrene Blanco, Stephan Krähenbühl, Raymond G SchliengerDrug Safety|February 4, 2006
The prevalence of potential drug-drug interactions in patients with heart failure at hospital dischargeBernhard Straubhaar, Stephan Krähenbühl, Raymond G SchliengerSwiss Medical Weekly|January 28, 2004
Appropriateness of serum level determinations of antiepileptic drugsNadia Affolter, Stephan Krähenbühl, Raymond G SchliengerSwiss Medical Weekly|December 31, 2002
Appropriateness of digoxin level monitoringMara R Mordasini, Stephan Krähenbühl, Raymond G SchliengerPraxis|March 25, 2000
[SIADH with epileptic seizures and coma in fluoxetine therapy]S C Romerio, V Radanowicz, R G SchliengerThe Annals of Pharmacotherapy|April 30, 2002
Tolterodine-associated acute mixed liver injuryRaymond G Schlienger, Martin J Keller, Stephan KrähenbühlPageof 7